Alexza Pharmaceuticals Inc. Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31)
Alexza Pharmaceuticals Inc. had Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) of $4.41 million as of 2016-03-31, per its 10-Q filed 2016-05-13.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:AssetsFairValueDisclosureRecurring · last filed 2016-05-13
- 2016-03-31: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $4.41M.
- 2015-12-31: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $6.81M.
- 2015-09-30: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $10.86M.
- 2015-06-30: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $14.92M.
| Period end | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) |
|---|---|
| 2016-03-31 | $4.41M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $6.81M 10-Q · filed 2016-05-13 |
| 2015-09-30 | $10.86M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $14.92M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $23.70M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $37.29M 10-K · filed 2016-03-28 |
| 2014-09-30 | $38.53M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $48.94M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $58.61M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $23.35M 10-K · filed 2015-03-13 |
| 2013-09-30 | $31.17M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $34.61M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $11.71M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $17.31M 10-Q · filed 2013-11-06 |
| 2011-12-31 | $14.62M 10-K · filed 2013-03-26 |